TP53 and cancer: Contrasting these observations are studies reporting that TP53 mutations are not sufficient to cause aneuploidy: monolayer cancer or non-transformed cell lines often remain diploid after p53 deletion/inactivation (Simoes-Sousa et al. 2018; Bunz et al. 2002; Haruki et al. 2001).